Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Oral Dis ; 21(5): 626-33, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25703825

RESUMO

OBJECTIVE: A large number of individuals have halitosis. The total amount of volatile sulfur compounds, which are the main cause of halitosis, has been correlated with periodontitis following bacterial infection. In this study, Porphyromonas gingivalis (Pg), a major periodontopathogenic bacterium, was isolated from patients with halitosis by the amplification of 16S rRNA, and the ability of isolated Pg to produce methyl mercaptan (CH3 SH) was determined to clarify the relationship between halitosis and Pg infection. MATERIALS AND METHODS: CH3 SH concentrations were measured in patients using Oral Chroma. The production of CH3 SH by Pg standard and clinical strains was also measured in vitro. Real-time PCR was performed to compare the expression of mgl mRNA (which encoded l-methionine-a-deamino-g-mercaptomethane-lyase) among the Pg strains. The production of CH3 SH and the expression of mgl mRNA were also determined to assess the effects of oriental medicine. RESULTS: The production of CH3 SH and the expression of mgl mRNA strongly correlated with each other in the presence of l-methionine. The expression of mgl mRNA by Pg W83 was strongly inhibited by magnoliaceae. CONCLUSION: The production of CH3 SH was correlated with the expression of mgl. Furthermore, the oriental medicine, magnoliaceae, may represent a potential treatment for halitosis.


Assuntos
Halitose/microbiologia , Porphyromonas gingivalis/genética , Porphyromonas gingivalis/metabolismo , RNA Mensageiro/biossíntese , Compostos de Sulfidrila/metabolismo , Adulto , Idoso , Anti-Infecciosos/farmacologia , Proteínas de Bactérias/efeitos dos fármacos , Infecções por Bacteroidaceae/metabolismo , Infecções por Bacteroidaceae/microbiologia , Medicamentos de Ervas Chinesas/farmacologia , Feminino , Humanos , Magnoliaceae , Masculino , Metionina/metabolismo , Metionina/farmacologia , Pessoa de Meia-Idade , Periodontite/metabolismo , Periodontite/microbiologia , Porphyromonas gingivalis/isolamento & purificação , RNA Mensageiro/efeitos dos fármacos , RNA Mensageiro/genética , Reação em Cadeia da Polimerase em Tempo Real/métodos , Adulto Jovem
2.
Oncology (Williston Park) ; 14(10 Suppl 9): 87-90, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11098503

RESUMO

In a step toward a clinical trial, the tumor response and survival of a weekday-on/weekend-off schedule of UFT was compared with its conventional daily schedule in a cancer-bearing rat model. The dose-intensive schedule--600 mg of UFT for 5 days followed by 2 drug-free days--amounts to a weekly dose similar to the conventional schedule of 400 mg/day. The weekday-on/weekend-off schedule provided increased survival and significantly greater antitumor activity than the conventional daily schedule, with no difference in adverse reactions. A study was also conducted in human subjects to measure fluorouracil (5-FU) concentrations that identified the pharmacokinetic activity during the 2 drug-free days of the weekday-on/weekend-off schedule. The plasma 5-FU concentration declined markedly after 24 hours, but the concentration in the tumor remained at a relatively high level after 2 days off the drug. A one-year clinical study evaluated the compliance and toxicity of the weekday-on/weekend-off UFT schedule as adjuvant chemotherapy for colorectal cancer. Based on the findings of all these studies, the weekday-on/weekend-off schedule for UFT as adjuvant chemotherapy for colorectal cancer can be recommended for a clinical trial.


Assuntos
Antimetabólitos Antineoplásicos/farmacocinética , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias Colorretais/tratamento farmacológico , Fluoruracila/farmacocinética , Sarcoma/tratamento farmacológico , Administração Oral , Animais , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Esquema de Medicação , Humanos , Masculino , Ratos , Sarcoma/veterinária , Análise de Sobrevida , Tegafur/administração & dosagem , Uracila/administração & dosagem
3.
Hum Reprod ; 14(5): 1361-7, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10325294

RESUMO

Hyaluronic acid (HA) stimulates the synthesis of interleukin (IL) 8, while dehydroepiandrosterone sulphate (DHEA-S) induces the expression of IL-8 and its receptor in the human cervical fibroblast. This has led us to investigate the effect of DHEA-S on HA-induced cervical ripening. Experiments were performed in pregnant rabbits using vaginal suppositories containing 1 mg HA, 30 mg DHEA-S, 30 mg DHEA-S + 0.1 mg HA, 30 mg DHEA-S + 1 mg HA, and 500 microl Witepsol-50 base (control). The effects were evaluated by measuring collagenase, gelatinase and elastase activities, water content, neutrophil infiltration, relative collagen concentration and histological assessment. The activities of collagenase, gelatinase and elastase were significantly increased in rabbits treated with DHEA-S + 1 mg HA compared with rabbits treated with DHEA-S + 0.1 mg HA (P < 0.009, P < 0.001, P < 0.009 respectively). Water content was markedly increased in rabbits treated with DHEA-S + 1 mg HA compared with DHEA-S + 0.1 mg HA treatment (P < 0.05). Neutrophil infiltration was markedly increased, while relative collagen concentration was significantly decreased with DHEA-S + 1 mg HA compared with the DHEA-S + 0.1 mg HA approach (P < 0.001, P < 0.002). The histology of cervices treated with DHEA-S + 1 mg HA showed the density of collagen to be markedly decreased, and collagen fibres irregularly separated. Increased vascularity with massive dilatation of blood vessels was also observed in these rabbits. We conclude that DHEA-S upregulates the HA-induced cervical ripening process.


Assuntos
Maturidade Cervical/efeitos dos fármacos , Sulfato de Desidroepiandrosterona/uso terapêutico , Ácido Hialurônico/uso terapêutico , Animais , Compostos Azo , Colágeno/metabolismo , Colagenases/metabolismo , Avaliação Pré-Clínica de Medicamentos , Sinergismo Farmacológico , Feminino , Gelatinases/metabolismo , Contagem de Leucócitos/efeitos dos fármacos , Neutrófilos/efeitos dos fármacos , Elastase Pancreática/metabolismo , Picratos , Gravidez , Coelhos , Coloração e Rotulagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA